EAR(Delisted)
Eargo·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About EAR
Eargo, Inc.
A medical device company that offers hearing aids designed for mild to moderate hearing loss in the United States
2665 North First Street, Suite 300, San Jose, California 95134
--
Eargo, Inc., was incorporated under the laws of the State of Delaware on November 12, 2010 as "Aria Innovations, Inc." and changed its name to "Eargo, Inc." in November 2014. The company is a medical device company dedicated to improving the quality of life of patients with hearing loss. The company developed the Eargo solution to create a hearing aid that consumers really want to use. The company's innovative products and go-to-market approach address key challenges of traditional hearing aid adoption, including social stigma, accessibility and cost.
Company Financials
EPS
EAR has released its 2023 Q3 earnings. EPS was reported at -0.71, versus the expected 0, missing expectations. The chart below visualizes how EAR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
EAR has released its 2023 Q3 earnings report, with revenue of 8.27M, reflecting a YoY change of 4.58%, and net profit of -17.33M, showing a YoY change of 65.77%. The Sankey diagram below clearly presents EAR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
